Healthcare Support Services

PASITHEA THERAPEUTICS CORP C/WTS 12/08/2026 (TO PUR COM)

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

KTTAW

KTTA

ARKG

SBIO

LABU

Pasithea Therapeutics Corporation (KTTA) has appointed Kartik Krishnan as chief medical officer effective May 1. Krishnan brings over 20 years of experience in clinical development and related fields, previously serving as CEO at OncoNano Medicines, a company focused on anti-cancer assets.

rttnews

Pasithea Therapeutics

iShares Global Healthcare

Ark Genomic Revolution ETF

Health Care Select Sector SPDR

SPDR S&P Biotech

First Trust NYSE Arca Biotech Index Fd

iShares US Pharma

Proshares Ultra Nasdaq Biotech

VanEck Biotech ETF

Invesco Biotechnology & Genome ETF

iShares Biotechnology ETF

VG Health

ALPS Medical Breakthrough

Direxion S&P Biotech Bull 3X

Pasithea Therapeutics Appoints Kartik Krishnan As CMO

Pasithea Therapeutics Announces Appointment of Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer | KTTA Stock News

StockTitan

Pasithea Therapeutics Announces Appointment of Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer | KTTA Stock News

Pasithea Therapeutics Announces Grant of Rare Pediatric Disease Designation (RPDD) by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) | KTTA Stock News

Pasithea Therapeutics Announces Grant of Rare Pediatric Disease Designation (RPDD) by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) | KTTA Stock News

Earnings Watch

PASITHEA THERAPEUTICS CORP C/WTS 12/08/2026 (TO PUR COM) | 10-K: FY2025 Revenue: USD 0

BTAI

MindBio to Raise Up to $650,000 for AI Intoxication Detection Expansion in Mining Sector

Tip Ranks

Invesco Nasdaq Biotechnology ETF

biote Corp.

Bioxcel Therap

Mustang Bio

MindBio to Raise Up to $650,000 for AI Intoxication Detection Expansion in Mining Sector

MindBio Therapeutics Corp. has announced the development of a proprietary edge computing platform for large-scale deployment of AI-driven voice analytics for drug and alcohol intoxication detection, targeting the mining industry. The company is collaborating with an engineering firm to create a hardware solution for real-time voice analysis. Initial deployment is planned in Chile, with potential expansion into other safety-critical sectors. The technology aims to address high rates of substance use in mining, presenting a significant market opportunity for non-invasive detection methods. CEO Justin Hanka emphasized the company's first-mover advantage in this field.

The newswire.ca

ESC NEUBASE THERAPEUTI

MindBio Advances Large-Scale Deployment of Voice Intoxication Detection Through Integrated Edge AI Hardware-Software Platform

DefenderStrike

Ranks in the top 50% of account holders by rate of return
Calculated based on your Longbridge (Singapore) A/C

Rate Of Return

NVIDIA

Grab

Venky21

Ranks in the top 20% of account holders by total assets
Calculated based on your Longbridge (Singapore) A/C

Total Assets

GRAB - CW25

Acrivon Therapeutics

Tela Bio

MeBridge

NVIDIA Return Rate

NVIDIA Diamond Holder

$LionGlobal Singapore Div Eq USD QDist(SG9999013478.FD)

PANW

Sssaint

Midnight Ninja

$Passenger Ground Transportation(IN00321.US)$Passenger Ground Transportation(IN00321.US)

PASITHEA THERAPEUTICS CORP C/WTS 12/08/2026 (TO PUR COM)(KTTAW.US)

Pasithea Therapeutics Appoints Kartik Krishnan As CMO

Pasithea Therapeutics Announces Appointment of Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer | KTTA Stock News

Pasithea Therapeutics Announces Grant of Rare Pediatric Disease Designation (RPDD) by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) | KTTA Stock News

PASITHEA THERAPEUTICS CORP C/WTS 12/08/2026 (TO PUR COM) | 10-K: FY2025 Revenue: USD 0

MindBio to Raise Up to $650,000 for AI Intoxication Detection Expansion in Mining Sector